NDC 0178-0740 Uribel
Methenamine,Sodium Phosphate,Monobasic,Monohydrate,Phenyl Salicylate,Methylene Blue,And - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 0178 - Mission Pharmacal Company
- 0178-0740 - Uribel
Product Characteristics
Product Packages
NDC Code 0178-0740-01
Package Description: 100 CAPSULE in 1 BOTTLE
Product Details
What is NDC 0178-0740?
What are the uses for Uribel?
What are Uribel Active Ingredients?
- HYOSCYAMINE SULFATE .12 mg/1
- METHENAMINE 118 mg/1 - An anti-infective agent most commonly used in the treatment of urinary tract infections. Its anti-infective action derives from the slow release of formaldehyde by hydrolysis at acidic pH. (From Martindale, The Extra Pharmacopoeia, 30th ed, p173)
- METHYLENE BLUE 10 mg/1 - A compound consisting of dark green crystals or crystalline powder, having a bronze-like luster. Solutions in water or alcohol have a deep blue color. Methylene blue is used as a bacteriologic stain and as an indicator. It inhibits GUANYLATE CYCLASE, and has been used to treat cyanide poisoning and to lower levels of METHEMOGLOBIN.
- PHENYL SALICYLATE 36 mg/1
- SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 40.8 mg/1
Which are Uribel UNII Codes?
The UNII codes for the active ingredients in this product are:
- METHENAMINE (UNII: J50OIX95QV)
- METHENAMINE (UNII: J50OIX95QV) (Active Moiety)
- SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE (UNII: 593YOG76RN)
- SODIUM CATION (UNII: LYR4M0NH37) (Active Moiety)
- PHENYL SALICYLATE (UNII: 28A37T47QO)
- PHENYL SALICYLATE (UNII: 28A37T47QO) (Active Moiety)
- METHYLENE BLUE (UNII: T42P99266K)
- METHYLENE BLUE CATION (UNII: ZMZ79891ZH) (Active Moiety)
- HYOSCYAMINE SULFATE (UNII: F2R8V82B84)
- HYOSCYAMINE (UNII: PX44XO846X) (Active Moiety)
Which are Uribel Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ANHYDROUS DIBASIC CALCIUM PHOSPHATE (UNII: L11K75P92J)
- GELATIN (UNII: 2G86QN327L)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- SHELLAC (UNII: 46N107B71O)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
What is the NDC to RxNorm Crosswalk for Uribel?
- RxCUI: 1087365 - methenamine 118 MG / sodium phosphate, monobasic 40.8 MG / phenyl salicylate 36 MG / methylene blue 10 MG / hyoscyamine sulfate 0.12 MG Oral Capsule
- RxCUI: 1087365 - hyoscyamine sulfate 0.12 MG / methenamine 118 MG / methylene blue 10 MG / phenyl salicylate 36 MG / sodium phosphate, monobasic 40.8 MG Oral Capsule
- RxCUI: 1087367 - Uribel 118 MG / 40.8 MG / 36 MG / 10 MG / 0.12 MG Oral Capsule
- RxCUI: 1087367 - hyoscyamine sulfate 0.12 MG / methenamine 118 MG / methylene blue 10 MG / phenyl salicylate 36 MG / sodium phosphate, monobasic 40.8 MG Oral Capsule [Uribel]
- RxCUI: 1087367 - Uribel (hyoscyamine sulfate 0.12 MG / methenamine 118 MG / methylene blue 10 MG / phenyl salicylate 36 MG / sodium phosphate, monobasic 40.8 MG) Oral Capsule
Which are the Pharmacologic Classes for Uribel?
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Oxidation-Reduction Activity - [MoA] (Mechanism of Action)
- Oxidation-Reduction Agent - [EPC] (Established Pharmacologic Class)
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[10] What is the End Marketing Date? - This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".